Abbott Laboratories ABT.BA Stock
Abbott Laboratories Price Chart
Abbott Laboratories ABT.BA Financial and Trading Overview
Abbott Laboratories stock price | 29293 ARS |
Previous Close | 12915 ARS |
Open | 13127 ARS |
Bid | 13250 ARS x N/A |
Ask | 13379.5 ARS x N/A |
Day's Range | 13040 - 13336 ARS |
52 Week Range | 6227 - 13600 ARS |
Volume | 576 ARS |
Avg. Volume | 1.05K ARS |
Market Cap | 45.78T ARS |
Beta (5Y Monthly) | 0.663028 |
PE Ratio (TTM) | 8.274823 |
EPS (TTM) | 5671.12 ARS |
Forward Dividend & Yield | 104 (0.82%) |
Ex-Dividend Date | July 13, 2023 |
1y Target Est | N/A |
ABT.BA Valuation Measures
Enterprise Value | 215.69B ARS |
Trailing P/E | 8.274823 |
Forward P/E | N/A |
PEG Ratio (5 yr expected) | N/A |
Price/Sales (ttm) | 1103.108 |
Price/Book (mrq) | 2502.9365 |
Enterprise Value/Revenue | 5.197 |
Enterprise Value/EBITDA | 20.119 |
Trading Information
Abbott Laboratories Stock Price History
Beta (5Y Monthly) | 0.663028 |
52-Week Change | 105.73% |
S&P500 52-Week Change | 20.43% |
52 Week High | 13600 ARS |
52 Week Low | 6227 ARS |
50-Day Moving Average | 12340.34 ARS |
200-Day Moving Average | 9722.33 ARS |
ABT.BA Share Statistics
Avg. Volume (3 month) | 1.05K ARS |
Avg. Daily Volume (10-Days) | 262 ARS |
Shares Outstanding | 869.47M |
Float | 6.9B |
Short Ratio | N/A |
% Held by Insiders | 0% |
% Held by Institutions | 0% |
Shares Short | N/A |
Short % of Float | N/A |
Short % of Shares Outstanding | N/A |
Dividends & Splits
Trailing Annual Dividend Rate | 1.96 |
Trailing Annual Dividend Yield | 0.015% |
5 Year Average Dividend Yield | N/A |
Payout Ratio | 0.0729 |
Last Split Factor |
Financial Highlights
Fiscal Year
Fiscal Year Ends | December 31, 2022 |
Most Recent Quarter (mrq) | March 31, 2023 |
Next Fiscal Year End | December 31, 2023 |
Profitability
Profit Margin | 13.98% |
Operating Margin (ttm) | 18.00% |
Gross Margin | 55.63% |
EBITDA Margin | 25.83% |
Management Effectiveness
Return on Assets (ttm) | 6.31% |
Return on Equity (ttm) | 15.93% |
Income Statement
Revenue (ttm) | 41.51B ARS |
Revenue Per Share (ttm) | 5.94 ARS |
Quarterly Revenue Growth (yoy) | -18.099% |
Gross Profit (ttm) | 24.58B ARS |
EBITDA | 10.72B ARS |
Net Income Avi to Common (ttm) | 5.78B ARS |
Diluted EPS (ttm) | 1609.4 |
Quarterly Earnings Growth (yoy) | -46.10% |
Balance Sheet
Total Cash (mrq) | 9.53B ARS |
Total Cash Per Share (mrq) | 1.37 ARS |
Total Debt (mrq) | 17.03B ARS |
Total Debt/Equity (mrq) | 45.73 ARS |
Current Ratio (mrq) | 1.678 |
Book Value Per Share (mrq) | 5.32075 |
Cash Flow Statement
Operating Cash Flow (ttm) | 8.66B ARS |
Levered Free Cash Flow (ttm) | 6.41B ARS |
Profile of Abbott Laboratories
Country | Argentina |
State | IL |
City | North Chicago |
Address | 100 Abbott Park Road |
ZIP | 60064-6400 |
Phone | 224 667 6100 |
Website | https://www.abbott.com |
Industry | Medical Devices |
Sector(s) | Healthcare |
Full Time Employees | 115000 |
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, Ménière's disease and vestibular vertigo, pain, fever, inflammation, and migraine, as well as provides anti-infective clarithromycin, influenza vaccine, and products to regulate physiological rhythm of the colon. The Diagnostic Products segment offers laboratory systems in the areas of immunoassay, clinical chemistry, hematology, and transfusion; molecular diagnostics systems that automate the extraction, purification, and preparation of DNA and RNA from patient samples, as well as detect and measure infectious agents; point of care systems; cartridges for testing blood; rapid diagnostics lateral flow testing products; molecular point-of-care testing for HIV, SARS-CoV-2, influenza A and B, RSV, and strep A; cardiometabolic test systems; drug and alcohol test, and remote patient monitoring and consumer self-test systems; and informatics and automation solutions for use in laboratories. The Nutritional Products segment provides pediatric and adult nutritional products. The Medical Devices segment offers rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular diseases; and diabetes care products, as well as neuromodulation devices for the management of chronic pain and movement disorders. Abbott Laboratories was founded in 1888 and is based in North Chicago, Illinois.
Q&A For Abbott Laboratories Stock
What is a current ABT.BA stock price?
Abbott Laboratories ABT.BA stock price today per share is 29293 ARS.
How to purchase Abbott Laboratories stock?
You can buy ABT.BA shares on the Buenos Aires exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Abbott Laboratories?
The stock symbol or ticker of Abbott Laboratories is ABT.BA.
Which industry does the Abbott Laboratories company belong to?
The Abbott Laboratories industry is Medical Devices.
How many shares does Abbott Laboratories have in circulation?
The max supply of Abbott Laboratories shares is 5.42B.
What is Abbott Laboratories Price to Earnings Ratio (PE Ratio)?
Abbott Laboratories PE Ratio is 5.16529370 now.
What was Abbott Laboratories earnings per share over the trailing 12 months (TTM)?
Abbott Laboratories EPS is 5671.12 ARS over the trailing 12 months.
Which sector does the Abbott Laboratories company belong to?
The Abbott Laboratories sector is Healthcare.